Hao Yuan Medicine and others establish a private equity investment fund in Chongqing.

Qichacha APP shows that Chongqing Yudu Life Sciences Pilot Private Equity Investment Fund Partnership was recently established, with a capital contribution of 300 million yuan, and its business scope includes engaging in equity investment through private equity funds. Qichacha equity penetration shows that the partnership is jointly funded by Haoyuan Pharma Investment Co., Ltd., a wholly-owned subsidiary of Haoyuan Pharma, and Chongqing Industrial Investment Mother Fund Partnership, among others.